US-based Volcano, a manufacturer of precision-guided therapy tools, has signed a definitive agreement to purchase Israeli software company Sync-Rx for an undisclosed sum.
Sync-Rx develops advanced software technologies to optimise and facilitate transcatheter cardiovascular interventions using automated online image processing.
The acquisition will enable Volcano to leverage Sync-Rx’s technology to build various advanced software features on its minimally invasive therapies and help clinicians achieve a more personalised treatment path for their patients, as well as documenting outcomes.
Volcano president and CEO Scott Huennekens said Sync-Rx’s technology will allow the company to present data in an integrated and intuitive way, which in beneficial for the hospital and physician.
"This transaction represents a strategic step in the advancement of our multi-modality platform," Huennekens said.
"We see the technology being incorporated seamlessly into our existing multi-modality system with the ability in the future to co-register IVUS images directly on to the angiogram
"Future applications for the Sync-Rx technology in other areas include co-registration of non-invasive imaging with real time intra-body physiology measurements and IVUS peripheral, forward looking IVUS, forward looking intra-cardiac (ICE), and OCT imaging."
The transaction is expected to be closed in December 2012.
